Elevated Soluble Vascular Cell Adhesion Molecule-1, Elevated Homocyst(E)inemia, and Hypertriglyceridemia in Relation to Preeclampsia Risk.
From: Center for Perinatal Studies (Swedish Medical Center, Seattle, Washington, USA. Surab.Vadachkoria@Swedish.org
American journal of hypertension : journal of the American Society of Hypertension
- Publish Date: Mar 2006
- ISSN: 0895-7061
- Volume: 19
- Issue: 3
- Pages: 235-42
- Medium: Print
- Language: English
- Citation (JAMA): Vadachkoria Surab, Woelk Godfrey B, Mahomed Kassam, et al. Elevated Soluble Vascular Cell Adhesion Molecule-1, Elevated Homocyst(E)inemia, and Hypertriglyceridemia in Relation to Preeclampsia Risk.. Am. J. Hypertens. Mar 2006;19:235-42
Abstract
BACKGROUND: We examined the relationship of maternal plasma concentrations of soluble vascular cell adhesion molecule-1 (sVCAM-1), a specific marker of endothelial dysfunction, and risk of preeclampsia. We also evaluated the relationship in the presence and absence of maternal hypertriglyceridemia and hyperhomocystein(e)mia. METHODS: A total of 170 women with preeclampsia and 184 control subjects were included in this case-control study analysis. Maternal postdiagnosis plasma sVCAM-1 concentrations were determined using immunoassays. Total plasma homocysteine (tHcy) was measured using high-performance liquid chromatography with electrochemical detection procedures; and triglyceride concentrations were determined using standard enzymatic procedures. Logistic regression procedures were used to estimate odds ratios (OR) and 95% confidence intervals (CI) adjusted for confounders. RESULTS: The relative risk of preeclampsia (as estimated by the OR) was increased 3.6-fold for women with sVCAM-1 concentrations >/=842 ng/mL compared with women who had lower concentrations (OR = 3.6; 95% CI 1.8 to 7.4). Of the three biological markers investigated, elevated sVCAM-1 concentrations was most strongly related to preeclampsia risk (OR = 4.6, 95% CI 1.6 to 13.5), followed by hyperhomocysten(e)mia (OR = 2.4, 95% CI 0.8 to 7.4) and hypertriglyceridemia (OR = 2.1, 95% CI 0.9 to 5.0). Compared with women who did not have any of the three risk factors, those with all three risk factors had an extremely high risk of preeclampsia (OR = 26.4; 95% CI 8.5 to 81.9). CONCLUSIONS: These findings suggest that elevated sVCAM-1 concentrations are associated with an increased risk of preeclampsia. Our findings extend the literature by documenting progressively increased risk with increasing numbers of biological markers of dyslipidemia and endothelial dysfunction.
Mesh Headings (Keywords): Adolescent, Adult, Biological Markers, Case-Control Studies, Female, Homocysteine, Humans, Hypertriglyceridemia, Odds Ratio, Pre-Eclampsia, Pregnancy, Risk Factors, Triglycerides, Vascular Cell Adhesion Molecule-1
Check for Full Text / PubMed Unique Identifier (PMID): 16500507
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.